1. Pretreatment Pan-Immune-Inflammation Value Efficiently Predicts Survival Outcomes in Glioblastoma Multiforme Patients Receiving Radiotherapy and Temozolomide
   Erkan Topkan et al, 2022, Journal of Immunology Research CrossRef
2. Blood-Based Biomarkers for Glioma in the Context of Gliomagenesis: A Systematic Review
   Hamza Ali et al, 2021, Frontiers in Oncology CrossRef
3. Baseline Serum C-Reactive Protein and Plasma Fibrinogen-Based Score in the Prediction of Survival in Glioblastoma
   Johannes Wach et al, 2021, Frontiers in Oncology CrossRef
4. Prognostic Value of Pretreatment Systemic Immune-Inflammation Index in Glioblastoma Multiforme Patients Undergoing Postneurosurgical Radiotherapy Plus Concurrent and Adjuvant Temozolomide
   Erkan Topkan et al, 2020, Mediators of Inflammation CrossRef
5. Immuno markers in newly diagnosed glioblastoma patients underwent Stupp protocol after neurosurgery: a retrospective series
   Lorena Gurrieri et al, 2023, Journal of Neuro-Oncology CrossRef
6. Pre-Treatment and Preoperative Neutrophil-to-Lymphocyte Ratio Predicts Prognostic Value of Glioblastoma: A Meta-Analysis
   Xin Guo et al, 2022, Brain Sciences CrossRef
7. Tannic Acid Attenuates Peripheral and Brain Changes in a Preclinical Rat Model of Glioblastoma by Modulating Oxidative Stress and Purinergic Signaling
   Natália Pontes Bona et al, 2022, Neurochemical Research CrossRef
8. The Prognostic Value of the Pretreatment Neutrophil/Lymphocyte Ratio in Patients with Glioblastoma Multiforme Brain Tumors: A Retrospective Cohort Study of Patients Treated with Combined Modality Surgery, Radiation Therapy, and Temozolomide Chemotherapy
   Agam Brenner et al, 2019, Oncology CrossRef
9. Systemic Inflammation Response Index Predicts Survival Outcomes in Glioblastoma Multiforme Patients Treated with Standard Stupp Protocol
   Erkan Topkan et al, 2020, Journal of Immunology Research CrossRef
10. A Simple Preoperative Blood Count to Stratify Prognosis in Isocitrate Dehydrogenase-Wildtype Glioblastoma Patients Treated with Radiotherapy plus Concomitant and Adjuvant Temozolomide
    Anne Clavreul et al, 2021, Cancers CrossRef
11. Systemic and local immunosuppression in glioblastoma and its prognostic significance
    Aleksei A. Stepanenko et al, 2024, Frontiers in Immunology CrossRef